Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

Completed

• Conditions: Chemotherapy; 75 Years Old and More; Cancer

• Registration Number: NCT03261128
• Lead Sponsor: Poitiers University Hospital

Brief Summary

Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.

Detailed Description

Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment:

* Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient.

* Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS).

* Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in

* Criterion analysis of D-FOG

Study Timeline

• Study First Submitted: 2017-08-04
• Study First Submitted QC: 2017-08-22
• Study First Posted: 2017-08-24
• Study Start: 2017-11-21
• Primary Completion: 2018-09-11
• Study Completion: 2018-12-05
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-28
• Last Update Posted: 2019-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients aged 75 years and over
• Carriers of diagnosed cancer (excluding hematology)
• Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic)
• Seen in nursing consultant
• Beginning an oncological treatment
• Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy
• Patient not opposed to participate in the study

Exclusion Criteria

• Patients under 75 years of age
• Having not had an IDE ad consultation
• During oncological treatment
• Receiving Oral Therapy or hormone therapy alone
• Treated by radiotherapy alone or surgery alone
• Not attending a day or week oncology hospital
• Refusal to participate in research

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment.	3 months	Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG

Trial Locations

Locations (1)

CHU; 🇫🇷 Poitiers, France